Von Massenhausen and collaborators analyzed the functional role of DDR2 in an in vivo xenograft model with or without dasatinib treatment and demonstrated that DDR2 inhibition blocked HNSCC cell migration and invasion [21]. Here, DDR2 is linked to head and neck squamous cell carcinoma.